These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G. Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576 [Abstract] [Full Text] [Related]
43. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL. J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673 [Abstract] [Full Text] [Related]
45. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. Prados MD, Edwards MS, Chang SM, Russo C, Davis R, Rabbitt J, Page M, Lamborn K, Wara WM. Int J Radiat Oncol Biol Phys; 1999 Jan 15; 43(2):279-85. PubMed ID: 10030250 [Abstract] [Full Text] [Related]
46. Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. Jakacki RI, Zeltzer PM, Boyett JM, Albright AL, Allen JC, Geyer JR, Rorke LB, Stanley P, Stevens KR, Wisoff J. J Clin Oncol; 1995 Jun 15; 13(6):1377-83. PubMed ID: 7751882 [Abstract] [Full Text] [Related]
48. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Grill J, Kalifa C, Doz F, Schoepfer C, Sainte-Rose C, Couanet D, Terrier-Lacombe MJ, Valteau-Couanet D, Hartmann O. Pediatr Neurosurg; 1996 Jul 15; 25(1):7-12. PubMed ID: 9055328 [Abstract] [Full Text] [Related]
49. [Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group]. Röttinger EM. Strahlenther Onkol; 1995 May 15; 171(5):303-4. PubMed ID: 7770788 [No Abstract] [Full Text] [Related]
50. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J, Cox T, Chong WK, Campbell RH, Bailey CC, Gattamaneni R, Picton S, Thorpe N, Mallucci C, English MW, Punt JA, Walker DA, Ellison DW, Machin D, Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee. Lancet Oncol; 2007 Aug 15; 8(8):696-705. PubMed ID: 17644039 [Abstract] [Full Text] [Related]
52. Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours. A report from the Australia and New Zealand Childhood Cancer Study Group (ANZCCSG). White L, Johnston H, Jones R, Mameghan H, Nayanar V, McWhirter W, Kellie S, Waters K, Toogood I. Cancer Chemother Pharmacol; 1993 Aug 15; 32(5):403-6. PubMed ID: 8339393 [Abstract] [Full Text] [Related]
53. Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group. Garvin JH, Selch MT, Holmes E, Berger MS, Finlay JL, Flannery A, Goldwein JW, Packer RJ, Rorke-Adams LB, Shiminski-Maher T, Sposto R, Stanley P, Tannous R, Pollack IF, Children's Oncology Group. Pediatr Blood Cancer; 2012 Dec 15; 59(7):1183-9. PubMed ID: 22949057 [Abstract] [Full Text] [Related]
54. Combined modality therapy for poorly differentiated gliomas of the posterior fossa in children: a Children's Cancer Group report. Bertolone SJ, Yates AJ, Boyett JM, Wallace D, Finlay JL, Children's Cancer Group. J Neurooncol; 2003 May 15; 63(1):49-54. PubMed ID: 12814254 [Abstract] [Full Text] [Related]
55. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial. Cohen BH, Zeltzer PM, Boyett JM, Geyer JR, Allen JC, Finlay JL, McGuire-Cullen P, Milstein JM, Rorke LB, Stanley P. J Clin Oncol; 1995 Jul 15; 13(7):1687-96. PubMed ID: 7602359 [Abstract] [Full Text] [Related]
58. Adjuvant chemotherapy with procarbazine, vincristine and prednisone for medulloblastomas. A preliminary report. Seiler RW, Bernasconi S, Berchtold W, Feldges A, Imbach P, Lüthi A, Plüss HJ, Vassella F, Wyss M, Wagner HP. Helv Paediatr Acta; 1981 Jul 15; 36(3):249-54. PubMed ID: 7275674 [Abstract] [Full Text] [Related]
59. Considerations in the radiation treatment of intracranial ependymoma. Prognosis in 24 own cases and results in published series after different techniques of radiation treatment. Glanzmann C, Horst W, Schiess K, Friede R. Strahlentherapie; 1980 Feb 15; 156(2):97-101. PubMed ID: 7355422 [Abstract] [Full Text] [Related]
60. Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945. Finlay JL, Geyer JR, Turski PA, Yates AJ, Boyett JM, Allen JC, Packer RJ. J Neurooncol; 1994 Feb 15; 21(3):255-65. PubMed ID: 7699420 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]